ENGN – enGene Holdings Inc. Common Stock

enGene Holdings Inc. Common Stock (ENGN) is an ETF.

Returns as of Oct 23, 2026: 1 week -6.6%.

Clinical-stage biotech developing genetic medicines for mucosal tissues. Lead candidate EG-70 targets non-muscle invasive bladder cancer.

Important ETFs